You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OR Regimen Refractory Marginal Zone Lymphoma Trial (obrutinib, rituximab)

Not yet recruiting
  • OR Regimen Refractory Marginal Zone Lymphoma
  • obrutinib, rituximab
  • (no location specified)
Nov 12, 2023

Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

Not yet recruiting
  • Refractory
  • +2 more
  • GTP regimen
  • (no location specified)
Sep 8, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Köln, Germany
    Local Institution - 0017
Dec 4, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))

Not yet recruiting
  • Refractory Cancer
  • Relapsed Cancer
  • Drug Sensitivity Test (DST)
  • Weston, Florida
    Lerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023

Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

Not yet recruiting
  • Meningioma
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 21, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 3, 2023

Cryoablation for Advanced and Refractory Desmoid Tumors

Recruiting
  • Desmoid Tumors
    • Strasbourg, France
      Service d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
    Oct 30, 2023

    Precision Medicine Treatment for Refractory Solid Tumors

    Recruiting
    • Refractory Solid Tumors
    • Next Generation Sequencing
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Sep 2, 2023

      Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

      Recruiting
      • Refractory Solid Tumors
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 22, 2023

      Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
      • (no location specified)
      Sep 5, 2023

      Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

      Recruiting
      • Diffuse Large B-cell Lymphoma Recurrent
      • Diffuse Large B Cell Lymphoma Refractory
      • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Oct 12, 2023

      Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • MCBC regimen
      • Bu/Cy regimen
      • (no location specified)
      Nov 13, 2023

      Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

      Not yet recruiting
      • Relapsed or Refractory Lymphomas
      • Advanced Solid Tumor
      • Los Alamitos, California
        Cancer and Blood Specialty Clinic
      Nov 9, 2023

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • Acute Myeloid Leukemia Refractory
      • (no location specified)
      Nov 9, 2023

      Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)

      Not yet recruiting
      • Relapsed/Refractory Large B-cell Lymphoma
      • (no location specified)
      Oct 6, 2023

      Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

      Not yet recruiting
      • Relapsed or Refractory Multiple Myeloma
      • (no location specified)
      Sep 20, 2023

      Refractory Status Epilepticus Trial in France (Isoflurane)

      Not yet recruiting
      • Refractory Status Epilepticus
      • Beuvry, France
      • +3 more
      Apr 13, 2023

      Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

      Completed
      • Relapsed or Refractory Non-Hodgkin's Lymphoma
      • Relapsed or Refractory Multiple Myeloma
      • BEBT-908 for injection
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Oct 9, 2023

      Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

      Recruiting
      • Relapse/Refractory Multiple Myeloma
      • DeepTag-GPRC5D Targeted CAR T-cells
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Oct 10, 2023

      Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

      Recruiting
      • Relapsed or Refractory CD19+ B-cell Lymphoma
      • +2 more
      • TBI-2001
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jul 26, 2023

      Relapsed or Refractory Diffuse Large B-cell Lymphoma Trial in Beijing (BEBT-908 for injection)

      Active, not recruiting
      • Relapsed or Refractory Diffuse Large B-cell Lymphoma
      • BEBT-908 for injection
      • Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciences
      Oct 8, 2023

      Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

      Enrolling by invitation
      • Refractory Systemic Lupus Erythematosus
      • +2 more
      • CNCT19 cell injection
      • Peking, China
        Xiaofeng Zeng
      Jul 3, 2023

      CD19-positive Relapsed or Refractory B-cell Malignancies Trial in Hefei (UTAA09 cells for infusion, Fludarabine,

      Not yet recruiting
      • CD19-positive Relapsed or Refractory B-cell Malignancies
      • UTAA09 cells for infusion
      • +2 more
      • Hefei, Anhui, China
        The First Affiliated Hospital of USTC (AnHui Provincial Hospital
      Oct 13, 2023